Biovaxys Technology Corp Stock Today
| BVAXF Stock | USD 0.06 0.0008 1.30% |
Performance10 of 100
| Odds Of DistressOver 71
|
Biovaxys Technology is trading at 0.0625 as of the 24th of April 2024. This is a 1.30 percent up since the beginning of the trading day. The stock's lowest day price was 0.0574. Biovaxys Technology has a very high chance of experiencing financial distress in the next few years of operation. However, it had a very ok returns during the last 90 days. Equity ratings for Biovaxys Technology Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
BioVaxys Technology Corp., a clinical biotechnology company, develops antiviral and anticancer vaccine platforms. BioVaxys Technology Corp. has a bioproduction agreement with WuXi Biologics Limited that produces SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH research collaboration with The Ohio State University, Wexner School of Medicine for BVX-0320 and agreement with Bioanalytical Systems, Inc. The company has 106.72 M outstanding shares. More on Biovaxys Technology Corp
Moving together with Biovaxys OTC Stock
| 0.61 | NVO | Novo Nordisk AS Earnings Call Next Week | PairCorr |
Moving against Biovaxys OTC Stock
| 0.78 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.61 | CSLLY | CSL | PairCorr |
| 0.6 | WXIBF | WuXi Biologics | PairCorr |
| 0.56 | CMXHF | CSL Limited | PairCorr |
| 0.43 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Biovaxys OTC Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biovaxys Technology's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biovaxys Technology or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Ron Babecoff |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Biovaxys Technology Corp [BVAXF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.73 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biovaxys Technology's market, we take the total number of its shares issued and multiply it by Biovaxys Technology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biovaxys Technology Corp classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 106.72 M outstanding shares.
Biovaxys Technology Corp has accumulated about 39.05 K in cash with (5.29 M) of positive cash flow from operations.
Check Biovaxys Technology Probability Of Bankruptcy
Ownership AllocationBiovaxys Technology holds a total of 106.72 Million outstanding shares. Biovaxys Technology Corp shows 18.94 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Biovaxys Ownership Details
Biovaxys Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of Biovaxys Technology jumping above the current price in 90 days from now is about 22.45%. The Biovaxys Technology Corp probability density function shows the probability of Biovaxys Technology otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Biovaxys Technology Corp has a beta of -1.9745 suggesting as returns on its benchmark rise, returns on holding Biovaxys Technology Corp are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Biovaxys Technology is expected to outperform its benchmark. Moreover, biovaxys Technology Corp has an alpha of 1.357, implying that it can generate a 1.36 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Biovaxys Technology to move above the current price in 90 days from now is about 22.45 (This Biovaxys Technology Corp probability density function shows the probability of Biovaxys OTC Stock to fall within a particular range of prices over 90 days) .
Biovaxys Technology Corp Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Biovaxys Technology market risk premium is the additional return an investor will receive from holding Biovaxys Technology long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biovaxys Technology. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Biovaxys Technology's alpha and beta are two of the key measurements used to evaluate Biovaxys Technology's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 7.61 | |||
| Semi Deviation | 7.42 | |||
| Standard Deviation | 9.96 | |||
| Variance | 99.22 |
Biovaxys Stock Against Markets
Picking the right benchmark for Biovaxys Technology otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Biovaxys Technology otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Biovaxys Technology is critical whether you are bullish or bearish towards Biovaxys Technology Corp at a given time. Please also check how Biovaxys Technology's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biovaxys Technology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
Biovaxys Technology Corporate Directors
Biovaxys Technology corporate directors refer to members of a Biovaxys Technology board of directors. The board of directors generally takes responsibility for the Biovaxys Technology's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Biovaxys Technology's board members must vote for the resolution. The Biovaxys Technology board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Moshe Many | Director | Profile | |
| George Lowell | Director | Profile | |
| Ruth Yakar | Independent Director | Profile | |
| Liora Lavsky | External Director | Profile |
How to buy Biovaxys OTC Stock?
Before investing in Biovaxys Technology, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Biovaxys Technology. To buy Biovaxys Technology stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Biovaxys Technology. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Biovaxys Technology stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Biovaxys Technology Corp stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Biovaxys Technology Corp stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Biovaxys Technology Corp, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Biovaxys Technology Corp?
The danger of trading Biovaxys Technology Corp is mainly related to its market volatility and OTC Stock specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biovaxys Technology is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biovaxys Technology. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biovaxys Technology Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovaxys Technology Corp. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Biovaxys OTC Stock analysis
When running Biovaxys Technology's price analysis, check to measure Biovaxys Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovaxys Technology is operating at the current time. Most of Biovaxys Technology's value examination focuses on studying past and present price action to predict the probability of Biovaxys Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovaxys Technology's price. Additionally, you may evaluate how the addition of Biovaxys Technology to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |